SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash of $142.54M in Q1 FY2026

Q1 FY2026 net change in cash was $142.54M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$142.54M+1577.3% QoQ
Last fiscal yearDec 2025
$80.09M— YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
80.09M USD
Year-over-year change
—

Net Change in Cash vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so net change in cash is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Net Change in Cash for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OCULOcular Therapeutix, Inc.LTM Mar 2026$317.02M USD+337.7%—609.2%
ALCAlcon Inc.LTM Sep 2026$216.6M USD+406.6%-37.0%2.0%
BLCOBausch + Lomb CorporationLTM Jun 2026$106M USD+453.3%-26.4%2.0%
SGPSpyGlass Pharma, Inc. Common StockFY2025$80.09M USD———
STAASTAAR Surgical CompanyLTM Apr 2026$41.25M USD-19.0%—14.2%
SGHTSight Sciences, Inc.LTM Mar 2026$23.54M USD+27.1%-28.1%29.6%
GKOSGlaukos CorporationLTM Jun 2026$12.92M USD-59.4%—2.1%
RXSTRxSight, Inc.LTM Mar 2026$10.43M USD+124.5%—8.2%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$7.45M USD-96.0%—97.8%
OCSOculis Holding AGLTM Mar 2026CHF 3.82M CHF-89.2%—758.5%
Peer median (excluding SGP) —+27.1%-28.1%14.2%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.